Skip to main content
Fig. 3 | Respiratory Research

Fig. 3

From: Influence of government-driven quality assessment program on patients with chronic obstructive pulmonary disease

Fig. 3

Comparison of annual changes of PFT conduction rate (a), inhaled LAMA prescription rate (b), and admission frequency (c) and all-cause mortality (d) between CQAP enrolled patients who visited the “1st grade” medical institution and those who visited the “5th grade” institution. PFT, pulmonary function test; COPD, chronic obstructive pulmonary disease. CQAP, COPD quality assessment program, LAMA, long-acting muscarine antagonists

Back to article page